🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great overview of #PrecisionMedicine in #PDAC by Eileen M O’Reilly at ESMO - Eur. Oncology #ESMOGI25 If you missed it, please watch it 📺 🧬NGS important, with RNA for fusions 🫶KRAS 🤞🏻MTAP 👀Claudin 18.2 🤝Molecular Tumor Board-ESMO recomendations available #ESMOAmbassadors Ben Westphalen

Excited to be an investigator within the NIH SMaHT Network! nature.com/articles/s4158… nature Broad Institute Tim Coorens Eunjung Alice Lee Flora Vaccarino

I am thrilled to share with the world a new preprint, spearheaded by the truly amazing Jose Reyes in partnership with Lowe Lab. Focused on the benign to malignant transition in PDAC, uncovering roles of plasticity, tissue remodeling and P53 -> biorxiv.org/content/10.110…

1/ Why is Ki-67 called Ki-67? And why am I attaching a photo of this beautiful city to the tweet? If you work in pathology or oncology, you’ve likely come across Ki-67 many times. But where does the name come from? A short 🧵 on the origins, function, and significance of Ki-67.

We mourn the loss of our beloved department member, Prof. Zelig Eshhar — a visionary immunologist and pioneer of CAR-T cell therapy. His groundbreaking work revolutionized cancer treatment and gave hope to countless patients.

I read this Cell paper that argues to have discovered a molecule (betaine) that mimics the geroprotective effects of exercise. This is a very valuable multi-omics resource, but the authors seemed to get caught in the rabbit hole of chasing a high-impact narrative🧵

Final version of nature paper on mutational signatures for colorectal cancer. nature.com/articles/s4158… Important implications for early onset colorectal cancer. Check out paper or video below. Thanks as always to Cancer Grand Challenges + team Wellcome Sanger Institute and Ludmil, Marcos UC San Diego

For an extensive overview of current and emerging #neoadjuvant #IO data across tumor types incl NSCLC, TNBC, CRC, esophagogastric + bladder cancers, melanoma and many more: So much we can learn from each other: immerse yourself! #ESMOGI25 Nature Cancer doi.org/10.1038/s43018…

Final COMPASS trial data advanced #PDAC ➡️268 WGS& 253RNA-seq ➡️basal-like& hi GRIm-S ⬇️OS, both unique TME inc CD8 variation,NB primaries vs mets ➡️LTS :HRD, KRAS WT ➡️KRAS major enriches basal, >type II DM ➡️LAPC≠intact SMAD4 ➡️47% receive 2nd line tx nature.com/articles/s4146…

💔 💔 💔 Many of us in Texas with young daughters are at most 1 degree of separation from these girls & their families. Just heartbreaking. 🙏 any girls still missing are found alive.

Excited to share our comprehensive pan-cancer analysis of the tumor microenvironment. Led by Bhavneet Bhinder, Paul Spellman & collaborators, we mapped the TME of >10,000 tumors, revealing 41 distinct immune/stromal patterns and their link to survival nature.com/articles/s4159…

In support of those impacted by flooding in Texas, Starlink is providing Mini kits for search and rescue efforts – ensuring connectivity even in dead zones – and one month of free service for thousands of customers in the region, including those who paused service so they can

Thank you all for reaching out and for prayers. All of the campers at my daughter’s camp are safe. We have her in our arms. Precious. Grieving for the Mystic families and for our children who will slowly start to comprehend what they have been through. We stood waiting for our

Hill Country flooding: Here’s how to give and receive help texastribune.org/2025/07/05/tex… via Texas Tribune

DNA methylation goes spatial! Introducing Spatial-DMT: a technology that co-profiles DNA methylation and transcriptome in the same tissue section. A fantastic collaboration with Wanding Zhou lab. Kudos to Chin Nien Lee Chin Nien Lee and Hongxiang Fu! biorxiv.org/content/10.110…

PanCAN is proud to announce new appointments and transitions within its Board of Directors and Scientific and Medical Advisory Board (SMAB). Joining the Board this year is Jon Mahrt, Chief Executive Officer of Optum Rx and Chief Growth Officer of Optum, a leading health

A very cool "pre-clinical-trial-on-chip" tool for CAR T cell development by Chao Ma and Weiqiang Chen (NYU Tandon)...with a small help from Matt Witkowski and our lab! nature.com/articles/s4155…

Thrilled to see our work led by yunhe liu published in Cancer Cell featured by Nature Custom Media nature nature.com/articles/d4247… Huge thanks to Ian Le Guillou for the thoughtful interview, beautifully written piece Aubrey Bloom Clayton Boldt, Ph.D. MD Anderson Cancer Center for their support